- Director 2025 to present
Executive record
Alpha ID: alpha:person:david-st-denisVersion: public-0As of: 2026-09-29
- Director
Key Claims
Biography
David St Denis has served as President and director since March 2025, and previously served as Chief Operating Officer since July 2017. He has held multiple leadership roles at Merck and Millennium Pharmaceuticals, and serves as CEO of v2vmedtech since April 2023. He brings extensive operational and strategic experience in the pharmaceutical and medical device industries.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Boards
Claims
Executive career
- 2026 to end not publishedExecutive title: President, Director (former Chief Operating Officer) · Organization not publishedAVR 10-K executive officers
- Dates not publishedExecutive title: President · Organization not publishedAVR DEF 14A director slate
Claims
Conflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
AVR 10-K executive officers
sec filing · Source published: Feb 26, 2026 · Retrieved: May 15, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Executive company: Executive at Anteris Technologies Global Corp. · Claim reviewed: May 15, 2026
- Executive title: Executive title: President, Director (former Chief Operating Officer) · Claim reviewed: May 15, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026
AVR DEF 14A director slate
sec filing · Source published: Nov 10, 2025 · Retrieved: May 15, 2026
Supports 7 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Board role: Board role: Director · Claim reviewed: May 15, 2026
- Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 15, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Executive company: Executive at Anteris Technologies Global Corp. · Claim reviewed: May 15, 2026
- Executive title: Executive title: President · Claim reviewed: May 15, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026
Open source
sec proxy · Source published: Nov 10, 2025 · Retrieved: Apr 25, 2026
Supports 1 claim
- Professional Role: Director at Anteris Technologies Global Corp. · Claim reviewed: May 15, 2026
Open source
public source · Source published: Date unavailable · Retrieved: Date unavailable
Supports 1 claim
- Board membership: Serves on the board of Anteris Technologies Global Corp. · Claim reviewed: May 15, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-29
- Biography
- published
- Board service
- published
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope

